Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 14
Submit an article Journal homepage
155
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Novel translocation of POGZ/STK11 in de novo mast cell leukemia with KIT D816H mutation

Kantaro Ishitsukaa Department of Hematology, University of Tsukuba Hospital, Ibaraki, JapanView further author information
,
Yuki Yoshizawaa Department of Hematology, University of Tsukuba Hospital, Ibaraki, JapanView further author information
,
Hidekazu Nishikiia Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanORCID Iconhttps://orcid.org/0000-0002-6277-4082View further author information
ORCID Icon,
Manabu Kusakabea Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2518-0776View further author information
ORCID Icon,
Yufu Itoc Department of Hematology, Tsuchiura Kyodo General Hospital, Ibaraki, JapanView further author information
,
Yukinori Inadomed Department of Pathology, National Hospital Organization Mito Medical Center, Ibaraki, JapanView further author information
,
Tatsuhiro Sakamotoa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
,
Takayasu Katoa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
,
Naoki Kuritaa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
,
Yasuhisa Yokoyamaa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
,
Naoshi Obaraa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
,
Yuichi Hasegawaa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
,
Yasuhito Nannyae Department of Hematology/Oncology, Institute of Medical Science, University of Tokyo, Tokyo, Japan;f Department of Pathology and Tumor Biology, Kyoto University, Kyoto, JapanView further author information
,
Seishi Ogawaf Department of Pathology and Tumor Biology, Kyoto University, Kyoto, JapanView further author information
,
Mamiko Sakata-Yanagimotoa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
&
Shigeru Chibaa Department of Hematology, University of Tsukuba Hospital, Ibaraki, Japan;b Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, JapanView further author information
 show all
Pages 3475-3479 | Received 13 Apr 2022, Accepted 04 Sep 2022, Published online: 20 Sep 2022

References

  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding sequence of the proto- oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest. 1993;92(4):1736–1744.
  • Piao X, Paulson R, van der Geer P, et al. Oncogenic mutation in the kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA. 1996;93(25):14665–14669.
  • Pardanani A. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol. 2019;94(3):363–377.
  • Miyawaki S, Sakamaki H, Ohtake S, et al. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan adult leukemia study group AML97 study. Cancer. 2005;104(12):2726–2734.
  • Suma S, Yokoyama Y, Momose H, et al. Salvage cord blood transplantation using a short-term reduced-intensity conditioning regimen for graft failure. Intern Med. 2022;61(11):1673–1679.
  • Georgin-Lavialle S, Lhermitte L, Dubreuil P, et al. Mast cell leukemia. Blood. 2013;121(8):1285–1295.
  • Ustun C, Reiter A, Scott BL, et al. Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol. 2014;32(29):3264–3274.
  • Jawhar M, Schwaab J, Meggendorfer M, et al. The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm. Haematologica. 2017;102(6):1035–1043.
  • Marinaccio C, Suraneni P, Celik H, et al. LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms. Cancer Discov. 2021;11(6):1398–1410.
  • Green AS, Chapuis N, Maciel TT, et al. The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. Blood. 2010;116(20):4262–4273.
  • Hezel AF, Bardeesy N. LKB1; linking cell structure and tumor suppression. Oncogene. 2008;27(55):6908–6919.
  • Jin F, Li X, Deng Y, et al. The orphan nuclear receptor NR4A1 promotes Fc ε RI – stimulated mast cell activation and anaphylaxis by counteracting the inhibitory LKB1/AMPK axis. Allergy. 2019;74(6):1145–1156.
  • Hwang SL, Li X, Lu Y, et al. AMP-activated protein kinase negatively regulates Fc ε RI-mediated mast cell signaling and anaphylaxis in mice. J Allergy Clin Immunol. 2013;132(3):729–736.e12.
  • Gao Q, Liang WW, Foltz SM, et al. Driver fusions and their implications in the development and treatment of human cancers. Cell Rep. 2018;23(1):227–238.e3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.